Last update 01 Nov 2024

Shenzhen Ruidi Bio-Pharmaceutical Co., Ltd.

Joint Venture Company | Subsidiary Company|
2018|
Guangdong Sheng, China

Overview

Tags

Respiratory Diseases
Infectious Diseases
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases1
Top 5 Drug TypeCount
Monoclonal antibody1
Top 5 TargetCount
alpha-toxin(Alpha-hemolysin)1

Related

2
Drugs associated with Shenzhen Ruidi Bio-Pharmaceutical Co., Ltd.
Tosatoxumab
Target
alpha-toxin
Mechanism
alpha-toxin inhibitors
Active Org.
Aridis Pharmaceuticals, Inc.Aridis Pharmaceuticals, Inc. [+4]
Originator Org.
Kenta Biotech AGKenta Biotech AG
Active Indication
Pneumonia, Ventilator-Associated [+2]
Inactive Indication
Pneumonia, Staphylococcal [+1]
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
Aerubumab
Target-
Mechanism
Immunomodulators
Active Org.-
Originator Org.
Harvard UniversityHarvard University
Active Indication-
Inactive Indication
Cystic Fibrosis [+2]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Shenzhen Ruidi Bio-Pharmaceutical Co., Ltd.
CTR20191544 / Active, not recruitingPhase 3
评价AR-301作为抗生素的联合治疗用于金黄色葡萄球菌性呼吸机相关性肺炎（VAP）治疗的有效性和安全性的III期临床研究
[Translation] A Phase III clinical study to evaluate the efficacy and safety of AR-301 as a combination therapy with antibiotics for the treatment of Staphylococcus aureus ventilator-associated pneumonia (VAP)
100 Clinical Results associated with Shenzhen Ruidi Bio-Pharmaceutical Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Shenzhen Ruidi Bio-Pharmaceutical Co., Ltd.
Login to view more data
100 Deals associated with Shenzhen Ruidi Bio-Pharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shenzhen Ruidi Bio-Pharmaceutical Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 29 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3 Clinical
1
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Tosatoxumab
 ( alpha-toxin )		Pneumonia, Ventilator-Associated
More
Phase 3
Aerubumab
Pneumonia
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free